ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
4,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
4,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6,2,Headache,Headaches NEC,Headaches,Nerv,N
6,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
8,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
9,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
11,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
12,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
13,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
14,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
16,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
16,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
17,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
18,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
18,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
18,4,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
19,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
22,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
23,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
24,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
25,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
26,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
27,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
29,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
30,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
30,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
31,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
33,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
34,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
36,1,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
36,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
36,4,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
37,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
38,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
38,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
39,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
40,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
41,1,Prostatic disorder,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
41,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
42,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
43,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
44,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
45,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
46,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
47,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
47,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
48,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,1,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
50,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
51,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
52,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
52,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
53,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
54,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
54,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
55,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
55,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
56,1,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
57,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
58,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
58,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
58,3,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
59,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
59,2,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
60,1,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
61,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
62,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
63,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
65,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
65,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
67,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
68,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
69,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
71,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
72,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
73,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
75,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
76,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
77,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
77,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
78,2,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
78,3,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
78,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
79,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
79,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
79,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
80,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
81,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
81,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
81,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
81,4,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
81,5,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
82,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
82,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
83,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
84,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
85,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
87,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
87,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
89,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
90,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
91,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
91,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
92,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
93,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
94,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
95,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
96,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
98,1,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
99,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
100,1,Fracture delayed union,Fracture complications,Fractures,Musc,N
101,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
101,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
102,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
103,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
103,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
104,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
105,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
105,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
105,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
105,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
107,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
107,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
108,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
109,2,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
110,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
111,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
113,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
114,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
116,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
117,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
118,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
120,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
120,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
121,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
121,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
123,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
124,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
124,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
125,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
126,1,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
127,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
128,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
129,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
130,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
131,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
132,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
133,1,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
133,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
134,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
134,4,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
134,5,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
134,6,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
134,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
134,8,Pyloric stenosis,Gastric disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
134,9,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
135,1,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
136,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
136,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
136,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
136,4,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
137,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
138,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
139,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
140,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
141,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
141,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,1,Athetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
142,2,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
143,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
143,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
143,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
143,4,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
143,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
144,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
145,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
146,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
146,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
146,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
147,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
147,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
147,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
147,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
148,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
148,3,Obsessive thoughts,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
149,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
150,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
151,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
151,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
151,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
151,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
151,5,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
151,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
152,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
153,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
153,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
153,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,2,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
156,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
157,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
158,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
159,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
159,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
160,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
160,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
161,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
162,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
163,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
163,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
163,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
164,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
165,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
166,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
167,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
168,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
169,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
169,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
170,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
171,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
171,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
171,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
172,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
173,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
173,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
174,1,Gambling disorder,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
175,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
176,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
176,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
177,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
178,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
178,2,Sleep attacks,Narcolepsy and associated conditions,Sleep disorders and disturbances,Psych,N
178,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,4,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
179,1,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
179,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
180,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,2,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
181,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
182,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
182,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
182,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
182,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
182,5,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
182,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
183,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
183,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
183,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
184,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
185,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
185,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
185,3,Sudden onset of sleep,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
186,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
188,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
189,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
190,1,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
190,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
190,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
190,4,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
190,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
191,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
192,1,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
193,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
193,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
193,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
194,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
195,1,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
195,2,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
195,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
196,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
196,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
197,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
198,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
199,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
199,2,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
199,3,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
200,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
200,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
200,3,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
200,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
200,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
200,6,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
200,7,Theft,Criminal activity,Legal issues,SocCi,N
201,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
201,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
202,1,Compulsive shopping,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
202,2,Excessive sexual fantasies,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
203,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
203,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
203,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
203,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
204,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
205,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
206,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
207,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
207,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
207,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
207,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
207,5,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
207,6,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
208,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
209,1,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
210,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
210,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
210,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
210,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
211,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
211,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
212,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
213,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
213,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
213,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
213,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
214,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
215,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
216,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
216,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
216,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
216,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
218,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
218,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
218,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
218,4,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
218,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
218,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
218,7,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
219,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
219,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
220,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
220,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
221,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
222,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
222,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
224,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
224,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
225,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
225,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
225,3,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
225,4,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
225,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
225,6,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
225,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
225,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
225,9,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
226,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,1,Excessive masturbation,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
227,2,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
228,1,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
229,1,Compulsive shopping,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
229,2,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
229,3,Gambling,Social issues NEC,Lifestyle issues,SocCi,N
229,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
229,5,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
229,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
230,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
230,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
231,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,2,Gambling disorder,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
232,1,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
232,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
232,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
232,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
233,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
233,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
234,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
235,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
236,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
236,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
237,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
237,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
238,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
238,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
239,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
240,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
240,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
241,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
241,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
241,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
241,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
242,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
242,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
242,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
242,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
243,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
244,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
245,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
245,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
245,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
246,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
246,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
246,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
247,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
247,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
248,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
248,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
249,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
250,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
250,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
251,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
251,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
251,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
251,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
252,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
252,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
254,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
254,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,3,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
254,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,1,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
256,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
257,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
258,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
259,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
260,1,Immobile,Disability issues,Lifestyle issues,SocCi,N
260,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
260,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
262,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
263,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
263,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
264,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
265,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
265,2,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
265,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
266,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
266,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
267,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
267,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
268,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
268,3,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
268,4,Penile pain,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
268,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
269,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
270,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
271,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
271,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
272,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
272,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
272,3,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
273,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
273,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
274,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
275,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
276,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
276,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
276,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
276,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
276,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
276,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
276,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
276,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
277,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
277,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
277,3,Dopamine dysregulation syndrome,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
277,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
277,5,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
277,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
277,7,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
277,8,Social problem,Social issues NEC,Lifestyle issues,SocCi,N
278,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
278,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
278,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
279,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
279,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
280,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
280,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
280,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
281,1,Headache,Headaches NEC,Headaches,Nerv,N
281,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
282,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
282,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
282,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
282,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
282,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
282,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
282,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
282,8,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
282,9,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
284,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
284,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,3,Headache,Headaches NEC,Headaches,Nerv,N
284,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
285,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
286,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
286,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
286,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
286,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
287,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
287,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
287,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
288,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
289,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
289,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
289,3,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
289,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
289,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
289,6,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
289,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
289,8,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
289,9,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
289,10,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
289,11,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
289,12,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
289,13,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
289,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
289,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
289,16,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
289,17,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
289,18,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
289,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
290,1,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
291,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
291,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
291,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
291,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
291,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
291,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
292,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
293,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
293,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
293,4,Narcolepsy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
293,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
294,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
294,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
295,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
295,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
296,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
296,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
296,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
297,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
298,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
298,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
298,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
298,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
298,5,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
298,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
298,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
298,8,Headache,Headaches NEC,Headaches,Nerv,N
298,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
298,10,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
298,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
298,12,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
298,13,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
298,14,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
298,15,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
299,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
299,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
300,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
300,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
300,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
301,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
302,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
303,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
304,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
305,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
305,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
305,3,Product blister packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
305,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
306,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
307,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
307,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
308,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
308,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
309,1,Chest injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
309,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
309,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
309,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
309,5,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
309,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
309,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
309,8,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
310,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
311,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
312,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
313,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
314,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
314,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
315,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
315,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
315,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
315,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
315,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
315,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
315,7,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
315,8,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,9,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
315,10,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
315,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
315,12,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
316,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
317,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
317,2,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
317,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
318,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
318,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
319,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
320,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
320,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
321,1,Faeces hard,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
321,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
321,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
321,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
322,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
323,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
323,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
324,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
324,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
324,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
324,4,Vaccination site bruising,Vaccination site reactions,Administration site reactions,Genrl,N
324,5,Vaccination site erythema,Vaccination site reactions,Administration site reactions,Genrl,N
324,6,Vaccination site oedema,Vaccination site reactions,Administration site reactions,Genrl,N
324,7,Vaccination site pain,Vaccination site reactions,Administration site reactions,Genrl,N
324,8,Vaccination site pruritus,Vaccination site reactions,Administration site reactions,Genrl,N
325,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
325,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
326,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
327,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
328,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
329,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
329,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
330,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
330,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
331,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
331,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
332,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
332,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
332,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
332,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
332,5,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
333,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
334,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
334,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
335,1,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
335,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
336,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
336,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
336,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
336,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
337,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
338,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
339,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
340,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
340,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
340,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
341,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
341,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
342,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
343,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
343,2,Coccydynia,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
343,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,4,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
343,5,Spinal column injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
344,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
344,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
344,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
344,5,Parkinsonian crisis,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
344,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
345,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
345,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
345,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
345,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
345,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
346,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
346,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
346,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
347,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
348,1,Diabetic coma,Coma states,Neurological disorders NEC,Nerv,N
348,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
348,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
348,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
348,5,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
349,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
349,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
350,1,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
350,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
350,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
351,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
351,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
351,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
352,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
352,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
352,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
352,4,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
352,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
352,6,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
352,7,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
352,8,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
353,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
353,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
353,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
353,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
353,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
353,6,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
353,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
353,8,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
353,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
353,10,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
353,11,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
353,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
354,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
354,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
354,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
354,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
355,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
355,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
355,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
355,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
356,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
357,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,2,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
358,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
359,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
359,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
360,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
360,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
360,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
360,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
361,1,Sweat discolouration,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
362,1,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
362,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
363,1,Dementia with Lewy bodies,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,Y
363,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
364,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
364,2,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
364,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
364,4,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
364,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
365,1,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
365,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
365,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
365,4,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
366,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
366,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
366,3,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
367,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
367,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
368,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
368,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
369,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
369,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
370,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
370,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
370,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
371,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
371,2,Nasal crusting,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
371,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
372,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
373,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
373,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
373,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
373,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
373,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
374,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
375,1,Aortic rupture,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
375,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
375,3,Freezing phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
375,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
375,5,Immobile,Disability issues,Lifestyle issues,SocCi,N
375,6,Immobile,Disability issues,Lifestyle issues,SocCi,N
375,7,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
375,8,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
375,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
376,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
376,2,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
377,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
377,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
378,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
378,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
378,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
378,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
378,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
378,6,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
379,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
379,2,Metatarsalgia,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
379,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
380,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
380,2,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
380,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
381,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
382,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
383,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
383,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
384,1,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
385,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
385,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
386,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
386,2,Headache,Headaches NEC,Headaches,Nerv,N
386,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
386,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
387,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
388,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
388,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
388,3,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
389,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
390,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
390,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
390,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
391,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
391,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
391,3,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
392,1,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
393,1,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
394,1,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
395,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
396,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
397,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
397,2,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
397,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
397,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
397,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
397,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
397,7,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
397,8,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
397,9,Physical deconditioning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
397,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,11,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
398,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
398,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
399,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
399,2,Pre-existing condition improved,General signs and symptoms NEC,General system disorders NEC,Genrl,N
400,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
400,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
400,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
400,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
400,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
401,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
401,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
402,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
402,2,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
402,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
403,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
403,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
404,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
405,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
406,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
407,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
407,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
407,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
407,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
408,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
408,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
408,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
409,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
409,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
409,4,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
409,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
409,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
409,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
410,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
410,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
410,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
410,4,Headache,Headaches NEC,Headaches,Nerv,N
410,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
410,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
411,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
411,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
412,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
412,2,Headache,Headaches NEC,Headaches,Nerv,N
412,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
412,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
412,5,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
413,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
413,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
414,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
415,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
416,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
416,2,Headache,Headaches NEC,Headaches,Nerv,N
417,1,Headache,Headaches NEC,Headaches,Nerv,N
418,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
419,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
419,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
419,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
419,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
420,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
421,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
421,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
422,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
422,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
422,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
422,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
422,5,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
423,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
423,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
423,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
424,1,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
425,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
425,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
426,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
427,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
427,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
428,1,Headache,Headaches NEC,Headaches,Nerv,N
428,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
429,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
429,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
430,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
430,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
430,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
431,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
432,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
432,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
432,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
432,4,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
432,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
432,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
433,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
433,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
434,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
435,1,Head deformity,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
435,2,Nuchal rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
436,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
436,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
436,3,Soft tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
437,1,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
437,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
437,3,Freezing phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
438,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
439,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
439,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
439,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
440,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
440,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
441,1,Resting tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
442,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
443,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
443,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
444,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
444,2,Headache,Headaches NEC,Headaches,Nerv,N
445,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
446,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
447,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
447,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
447,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
447,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
447,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
448,1,Compulsive sexual behaviour,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
448,2,Compulsive shopping,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
449,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
450,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
450,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
450,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
451,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
451,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
452,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
453,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
453,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
454,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
454,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
455,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
456,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
